Vera Therapeutics (VERA) had the highest return between January 1, 2024 and January 31, 2024 by a small-cap US stock, returning 139.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vera Therapeutics (VERA) | 1/1/2024 - 1/31/2024 | 139.61% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/1/2024 - 1/31/2024 | 127.65% |
Praxis Precision Medicines (PRAX) | 1/1/2024 - 1/31/2024 | 96.18% |
Akso Health Group ADR (AHG) | 1/1/2024 - 1/31/2024 | 95.24% |
ADC Therapeutics (ADCT) | 1/1/2024 - 1/31/2024 | 87.95% |
Arcutis Biotherapeutics (ARQT) | 1/1/2024 - 1/31/2024 | 85.17% |
Dianthus Therapeutics (DNTH) | 1/1/2024 - 1/31/2024 | 84.81% |
Real Brokerage (REAX) | 1/1/2024 - 1/31/2024 | 79.25% |
Clene (CLNNW) | 1/1/2024 - 1/31/2024 | 73.48% |
Astria Therapeutics (ATXS) | 1/1/2024 - 1/31/2024 | 72.58% |
Dyne Therapeutics (DYN) | 1/1/2024 - 1/31/2024 | 64.36% |
SEALSQ (LAES) | 1/1/2024 - 1/31/2024 | 63.33% |
Edgewise Therapeutics (EWTX) | 1/1/2024 - 1/31/2024 | 63.13% |
Mereo BioPharma Group PLC ADR (MREO) | 1/1/2024 - 1/31/2024 | 62.66% |
Neurogene (NGNE) | 1/1/2024 - 1/31/2024 | 55.62% |
Immunome (IMNM) | 1/1/2024 - 1/31/2024 | 53.43% |
Establishment Labs (ESTA) | 1/1/2024 - 1/31/2024 | 51.04% |
Codere Online US (CDRO) | 1/1/2024 - 1/31/2024 | 51.03% |
Cullinan Oncology LLC (CGEM) | 1/1/2024 - 1/31/2024 | 50.2% |
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 1/1/2024 - 1/31/2024 | 47.3% |
Neuropace (NPCE) | 1/1/2024 - 1/31/2024 | 45.76% |
Verastem (VSTM) | 1/1/2024 - 1/31/2024 | 44.35% |
Intuitive Machines (LUNR) | 1/1/2024 - 1/31/2024 | 43.73% |
Heron Therapeuti (HRTX) | 1/1/2024 - 1/31/2024 | 43.45% |
Axogen (AXGN) | 1/1/2024 - 1/31/2024 | 43.05% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
